Translational cancer immunology grants supporting bidirectional lab–clinic research that advances immunotherapy—applying basic science to clinical problems, informing discovery from clinical observations, and improving models for testing and delivery.
Eligibility Criteria:
-
Tenure-track assistant professor or higher by award activation (or institutional letter confirming rank by start).
-
No citizenship restrictions; work may be conducted worldwide at non-profit institutions.
-
Not eligible: for-profit institutions.
Funding Details:
-
USD 300,000 over 2 years (indirect costs up to 10% in addition to the award).
-
Possible extension: additional USD 300,000 over 2 years (by invitation, based on progress).
-
Co-funding opportunity with Chordoma Foundation for chordoma-focused projects (models and biospecimens available).
Deadline:
-
Letter Of Intent: December 1 (5:00 p.m. ET).
-
Invited Full Application: March 1 (5:00 p.m. ET).
-
Earliest Award Start: July 1 (awards activate on the first of the month).
Where To Go For Further Information:
-
Questions: [email protected]